Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma

Cancer Research

Volumn 61, Issue 13, 2001, Pages 5202-5206

  Arcinas, Magdalena ^a   Heckman, Caroline A ^a   Mehew, John W ^a   Boxer, Linda M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MYC PROTEIN; PROTEIN BCL 2;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DNA FOOTPRINTING; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ALLELES; BINDING SITES; BLOTTING, NORTHERN; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE PROGRESSION; DNA FOOTPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, MYC; HUMANS; LYMPHOMA, FOLLICULAR; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 0035394360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/Immunoglobulin transcript resulting from the t(14;18) translocation
2. Expression of bcl-2 and bcl-2-Ig fusion transcripts in normal and neoplastic cells
3. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma
4. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18)
5. Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2
6. Insights from Bcl-2 and Myc: Malignancy involves abrogation of apoptosis as well as sustained proliferation
7. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
8. Apoptotic cell death induced by c-myc is inhibited by bcl-2
9. Cooperative interaction between c-myc and bcl-2 proto-oncogenes
10. Myc-mediated apoptosis is blocked by ectopic expression of bcl-2
11. A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells
12. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
13. NF-κB sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma
14. novel NF-κB element within exon 1 of the murine c-myc gene
15. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors
16. The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma
17. A clinical trial of anti-idiotype therapy for B cell malignancy
18. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas
19. Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis
20. In vivo footprinting of a muscle specific enhancer by ligation-mediated PCR
21. In vivo footprinting of the human α-globin locus upstream regulatory element by guanine and adenine ligation-mediated polymerase chain reaction
22. Genomic organization of the translocations (8;14) and (14;18) in a new lymphoma cell line
23. MYC rearrangements in histologically progressed follicular lymphomas
24. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Lyl + B-cell lymphoma
25. A novel VH to VHDJH joining mechanism in heavy-chain- negative (null) pre-B cells results in heavy-chain production
26. V(D)J recombinase activity in a subset of germinal center B lymphocytes
27. Rearrangement of λ light chain genes in mature B cells in vitro and in vivo. Function of reexpressed recombination-activating gene (RAG) products
28. V(D)J recombination in mature B cells: A mechanism for altering antibody responses
29. NF-κB activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer